These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32417790)

  • 21. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
    Chen TH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the SMN1 and NAIP genes in Iranian patients with spinal muscular atrophy.
    Derakhshandeh-Peykar P; Esmaili M; Ousati-Ashtiani Z; Rahmani M; Babrzadeh F; Farshidi S; Attaran E; Sajedifar MM; Farhud DD
    Ann Acad Med Singap; 2007 Nov; 36(11):937-41. PubMed ID: 18071605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
    Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
    Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
    Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
    Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
    Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
    PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.
    Cruz R; Belter L; Wasnock M; Nazarelli A; Jarecki J
    Clin Ther; 2019 May; 41(5):943-960.e4. PubMed ID: 31056304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy.
    Liu Z; Zhang P; He X; Liu S; Tang S; Zhang R; Wang X; Tan J; Peng B; Jiang L; Hong S; Zou L
    BMC Neurol; 2016 Aug; 16(1):141. PubMed ID: 27534852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada.
    Chen G; Sharif B; Gerber B; Farris MS; Cowling T; Cabalteja C; Wu JW; Maturi B; Klein-Panneton K; Jean K Mah
    J Med Econ; 2021 Nov; 24(sup1):51-59. PubMed ID: 34906030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of copy number of SMN1 and SMN2 with clinical phenotypes in children with spinal muscular atrophy].
    Zhang YH; Zhang YQ; Zhu BS; He J; Wang L; Tang XH; Guo JJ; Jin CC; Chen H; Zhang J; Zhang JM; Li L
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Mar; 21(3):239-243. PubMed ID: 30907347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients.
    Amara A; Adala L; Ben Charfeddine I; Mamaï O; Mili A; Lazreg TB; H'mida D; Amri F; Salem N; Boughammura L; Saad A; Gribaa M
    Eur J Paediatr Neurol; 2012 Mar; 16(2):167-74. PubMed ID: 21821450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.
    Wirth B; Brichta L; Schrank B; Lochmüller H; Blick S; Baasner A; Heller R
    Hum Genet; 2006 May; 119(4):422-8. PubMed ID: 16508748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis of spinal muscular atrophy in Egyptians.
    Shawky RM; Abd el-Aleem K; Rifaat MM; Moustafa A
    East Mediterr Health J; 2001; 7(1-2):229-37. PubMed ID: 12596974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report.
    Jiang J; Huang J; Gu J; Cai X; Zhao H; Lu H
    BMC Med Genet; 2019 Dec; 20(1):204. PubMed ID: 31888525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletions in the SMN and NAIP genes in patients with spinal muscular atrophy in Croatia.
    Sertić J; Barisić N; Sostarko M; Bosnjak N; Culić V; Cvitanović L; Ferencak G; Brzović Z; Stavljenić-Rukavina A
    Coll Antropol; 1997 Dec; 21(2):487-92. PubMed ID: 9439064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy patients from India.
    Kesari A; Idris MM; Chandak GR; Mittal B
    Exp Mol Med; 2005 Jun; 37(3):147-54. PubMed ID: 16000867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia.
    Sarv S; Kahre T; Vaidla E; Pajusalu S; Muru K; Põder H; Gross-Paju K; Ütt S; Žordania R; Talvik I; Õiglane-Shlik E; Muhu K; Õunap K
    Front Genet; 2021; 12():796862. PubMed ID: 35003227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.